M
Mustafa Özcürümez
Researcher at Ruhr University Bochum
Publications - 22
Citations - 155
Mustafa Özcürümez is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 10 publications receiving 99 citations.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 antibody testing-questions to be asked.
Mustafa Özcürümez,Andreas Ambrosch,Oliver Frey,Verena Haselmann,Stefan Holdenrieder,Michael Kiehntopf,Michael Neumaier,Michael Walter,Michael Walter,Folker Wenzel,Roman Wölfel,Harald Renz +11 more
TL;DR: The recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses issues based on the currently available datasets in this rapidly moving field of antibody testing.
Journal ArticleDOI
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
Verena Haselmann,Mustafa Özcürümez,Frank Klawonn,Volker Ast,Catharina Gerhards,Romy Eichner,Victor Costina,Gerhard Dobler,Wolf J. Geilenkeuser,Roman Wölfel,Michael Neumaier +10 more
TL;DR: The results of this pilot EQA scheme indicate a very heterogeneous landscape of anti-SARS-CoV-2 serological testing and are an incentive for laboratories to participate in upcoming open EQA schemes that are needed to achieve a harmonization of test results and to improve serologicalTesting.
Journal ArticleDOI
Determination and verification of reference interval limits in clinical chemistry. Recommendations for laboratories on behalf of the Working Group Guide Limits of the DGKL with respect to ISO Standard 15189 and the Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations (Rili-BAEK)
TL;DR: The German Society for Clinical Chemistry and Laboratory Medicine (DGKL) Working Group GL (WG-GL) has developed recommendations to support medical laboratories in the management of GL.
Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD.
Anna-Sophia Leven,RK Gieseler,Martin Schlattjan,Thomas Schreiter,Marco Niedergethmann,Theodor Baars,Hideo A. Baba,Mustafa Özcürümez,Jan-Peter Sowa,Ali Canbay +9 more
TL;DR: In this article, the role of visceral white adipose tissue (vWAT) in the progression of NAFLD with its sub entities non-alcoholic fatty liver and steatohepatitis (NAFL; NASH) is investigated.